Improving frequency of urinary albumin testing in type 2 diabetes in primary care — An analysis of cross-sectional studies in Denmark
Open Access
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Primary Care Diabetes
- Vol. 15 (6) , 1007-1011
Abstract
No abstract availableKeywords
Funding Information
- Meso Scale Diagnostics
- AstraZeneca
- Boehringer Ingelheim
- Bayer
- Novo Nordisk
- Amgen
- Sanofi
This publication has 26 references indexed in Scilit:
- Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefitsKidney International, 2017
- Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trialDiabetologia, 2016
- Empagliflozin and Progression of Kidney Disease in Type 2 DiabetesNew England Journal of Medicine, 2016
- Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trialDiabetes, Obesity and Metabolism, 2015
- Microalbuminuria: A parameter that has changed diabetes careDiabetes Research and Clinical Practice, 2015
- Kidney Disease and Increased Mortality Risk in Type 2 DiabetesJournal of the American Society of Nephrology, 2013
- Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKDKidney International, 2012
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesNew England Journal of Medicine, 2008
- Stabilized incidence of diabetic patients referred for renal replacement therapy in DenmarkKidney International, 2006
- Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspectiveKidney International, 2006